Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

Mark S. Soloway, Stephen W. Hardeman, David P. Hickey et al. · Cancer · 1988 · 638 citations

Medicine, Oncology, Radiology +17

Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)

Maha Hussain, Catherine M. Tangen, Celestia S. Higano et al. · Journal of Clinical Oncology · 2006 · 507 citations · Full text

Medicine, Oncology, Urology +17

Nomogram for Overall Survival of Patients With Progressive Metastatic Prostate Cancer After Castration

Òren Smaletz, Howard I. Scher, Eric J. Small et al. · Journal of Clinical Oncology · 2002 · 386 citations

Medicine, Oncology, Urology +16

Time to prostate‐specific antigen nadir independently predicts overall survival in patients who have metastatic hormone‐sensitive prostate cancer treated with androgen‐deprivation therapy

Toni K. Choueiri, Wanling Xie, Anthony V. D’Amico et al. · Cancer · 2009 · 145 citations · Full text

Medicine, Oncology, Urology +13

Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy

Matthew R. Cooperberg, Shiro Hinotsu, Mikio Namiki et al. · Journal of Clinical Oncology · 2009 · 124 citations · Full text

Medicine, Oncology, Urology +17